should recist-pd lead to a change of treatment? laure fournier, m.d.
Published 12 years ago • 703 plays • Length 10:20Download video MP4
Download video MP3
Similar videos
-
25:25
resisting recist- new methods of assessing tumour response to therapy, r gore
-
11:15
should response to 1st-line agents guide the choice of treatment in 2nd-line? camillo porta, m.d.
-
9:21
choi criteria
-
53:20
immunotherapy and immune response criteria: what the radiologist should know
-
24:01
alport syndrome: what you need to know - anjay rastogi, md, phd | ucla core kidney program
-
5:13
continuing anti–pd-1 therapy beyond recist progression
-
1:06:09
parkinson's 101 for the newly diagnosed: overview of pd
-
1:06:11
pd edu: parkinson's isn't what we think— and a solution in sight
-
13:59
understanding chronic kidney disease (ckd)
-
0:38
best foods for chronic kidney disease
-
1:17
optimal therapy sequencing in kidney cancer
-
20:03
oncology. recist 1.1
-
8:40
chronic kidney disease - causes, symptoms, diagnosis, treatment, pathology
-
3:15
slowing the progression of chronic kidney disease
-
0:35
the value of patient-centered outcomes research in the real world
-
2:54
are you or someone you know getting frail?
-
1:09
why are patients with kidney disease often not considered for clinical trials?
-
12:08
26. from a wide array, choosing the best treatment for parkinson's disease | dr. natalie diaz
-
14:59
should device-aided treatment be given earlier in parkinson’s disease?
-
1:48
patient preferences change throughout disease process
-
1:05
are you at risk for kidney disease?